TL;DR
Med-El, the Austrian hearing implant manufacturer, has launched the TICI Unico, a cochlear implant designed to work entirely under the skin with no externally visible parts. The device follows promising feasibility study results and early European surgeries, and the company says it can be worn 24/7, including while sleeping, showering, and swimming.
Med-El has officially launched the TICI Unico, a cochlear implant designed to function entirely beneath the skin with no externally visible components, the Innsbruck-based manufacturer announced. The company describes the device as the world’s only totally invisible cochlear implant and the first commercial product of its kind, following years of development, feasibility studies, and early surgeries in Europe.
Turn quiet afternoons into listening time
- Thousands of audiobooks, podcasts and originals
- Listen on your phone, tablet or Echo — also offline
- Cancel anytime
Unlike conventional cochlear implants, which require an external sound processor worn behind the ear or on the head, the TICI Unico is designed to work completely subcutaneously, including the microphone, according to Med-El. The company says this means users hear without any external hardware during everyday use, and that the implant can function around the clock — while sleeping, showering, and swimming — since implanted components are not affected by water.
The launch follows Med-El’s reported promising feasibility study results for its TICI platform and early surgeries with the technology conducted in Europe. The TICI Unico is the commercial product resulting from that research and clinical work, and its development has been tracked by the hearing healthcare industry over several years.
The announcement adds to a period of notable activity for Med-El, which recently acquired two gene therapy programs from Rescue Hearing and expanded its device connectivity portfolio through a collaboration with Starkey on bimodal Bluetooth. The privately held company develops and manufactures cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants.
Why an Invisible Implant Matters
The launch addresses a longstanding goal within the cochlear implant field: delivering hearing restoration through a device that is imperceptible to others. Med-El positions the TICI Unico for patients who prioritize discretion and convenience alongside hearing performance, a segment the industry has long viewed as underserved.
The push toward fully implantable devices has intensified across the industry in recent years, with multiple manufacturers exploring designs that eliminate external components. Med-El’s device now enters the market as the company’s answer to that demand. CEO Ingeborg Hochmair said she hopes the technology will widen access, stating she hopes “it will open the door to hearing for many more people than currently are interested in cochlear implants.”
Products Worth Considering

Levoit Vital 100S-P Air Purifier with Washable Pre-Filter

Blueair 2-in-1 Air Purifier and Humidifier for Rooms up to 1,726 sq. ft.

Therabody Theragun Relief Massage Gun, 3-Speed, Navy
As an affiliate, we earn on qualifying purchases.
From Feasibility Studies to Market
Med-El, headquartered in Innsbruck, Austria, is a privately held hearing implant developer founded by Ingeborg Hochmair, who has led the company’s cochlear implant innovation for decades. The TICI Unico launch follows the company’s reported feasibility study results for the TICI platform and early surgeries in Europe using the technology.
The commercial launch arrives amid broader company expansion, including the acquisition of two gene therapy programs from Rescue Hearing and a connectivity collaboration with hearing aid maker Starkey on bimodal Bluetooth. Additional product information is available at medel.com.
“TICI Unico is a new category of an implant. It is totally new and it is the realization of a dream that I have had for a very long time.”
— Ingeborg Hochmair, Med-El co-founder and CEO
What Med-El Has Not Detailed
Med-El has not yet published detailed clinical performance data for the commercial TICI Unico, including hearing outcomes, battery life, recharging methods, or longevity of the fully implanted system. The scope and size of the earlier feasibility studies have not been specified in the announcement.
It is also unclear which markets the device will be available in first, what the regulatory status is in individual countries, which patients will be eligible, and what the device will cost. Claims such as “totally invisible” and “world’s only” are the company’s own descriptions and have not been independently verified.
Rollout and Clinical Evidence Ahead
Watch for details on market availability and regulatory approvals in individual countries, as Med-El has not yet announced a rollout schedule. Independent clinical data on real-world performance — including hearing outcomes, durability, and how the implanted microphone performs in everyday conditions — will be a key measure of the device’s impact.
Competitors pursuing fully implantable cochlear implant designs may also accelerate their own programs in response, and hearing industry observers will be watching adoption rates among patients who have previously hesitated to pursue cochlear implantation.
Key Questions
What makes the TICI Unico different from a conventional cochlear implant?
Conventional cochlear implants require an external sound processor worn behind the ear or on the head. The TICI Unico is designed to function entirely under the skin, including the microphone, with no external hardware during everyday use, according to Med-El.
Can the TICI Unico be used while sleeping, showering, or swimming?
Med-El says the device works 24/7, including while sleeping, showering, and swimming, because the implanted components sit beneath the skin and are not affected by water.
Has the TICI Unico been tested in patients?
Med-El has reported promising feasibility study results for its TICI platform and conducted early surgeries in Europe. Detailed clinical performance data for the commercial device has not yet been published.
Who is Med-El?
Med-El is a privately held hearing implant company headquartered in Innsbruck, Austria. It develops and manufactures cochlear implants, middle ear implants, bone conduction implants, and auditory brainstem implants.
When and where will the TICI Unico be available?
Med-El has not announced specific market availability, regulatory approvals, eligibility criteria, or pricing. Readers can find additional information at medel.com and should consult a qualified hearing specialist about their individual situation.
Source: rss
